Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hepatitis C virus inhibitors

Hepatitis C virus inhibitors

US Patent 8552047 · Granted Oct 8, 2013

Estimated economic value: $332,795,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of human immunodeficiency virus replication2024
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency v2022
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency v2022
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency v2022
Salts of prodrugs of piperazine and substituted piperidine antiviral agents2022
Stereoselective synthesis and process for the manufacturing of 2′-deoxynucleosid2022
2′-halogenated-4′-thio-2′-deoxy-5-azacytidine analogs and use thereof2022
Benzofuran derivatives for the treatment of hepatitis C2021
Inhibitors of human immunodeficiency virus replication2021
Inhibitors of human immunodeficiency virus replication2021
Inhibitors of human immunodeficiency virus replication2021
Hepatitis C virus inhibitors2020